Theravance Biopharma (TBPH) Shares Outstanding (Entity) (2013 - 2026)

Theravance Biopharma (TBPH) Shares Outstanding (Entity) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 139.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.54 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 214.24 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 113.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 575.47 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.73 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 218.28 Mn
10 Theravance Biopharma 880.59 Mn 492.93 Mn - 51.89 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 51.89 Mn
Mar 31, 2026 51.52 Mn
Dec 31, 2025 51.07 Mn
Sep 30, 2025 50.67 Mn
Jun 30, 2025 50.36 Mn
Mar 31, 2025 50.00 Mn
Dec 31, 2024 49.47 Mn
Sep 30, 2024 49.17 Mn
Jun 30, 2024 48.92 Mn
Mar 31, 2024 48.57 Mn
Dec 31, 2023 48.09 Mn
Sep 30, 2023 50.82 Mn
Jun 30, 2023 53.69 Mn
Mar 31, 2023 60.54 Mn
Dec 31, 2022 65.23 Mn
Sep 30, 2022 67.37 Mn
Jun 30, 2022 76.43 Mn
Mar 31, 2022 76.08 Mn
Dec 31, 2021 74.44 Mn
Sep 30, 2021 73.70 Mn